The purpose of this document is to provide general guidance for empiric therapy based on the results of the rapid blood culture identification panel (BCID-II) used at BCH Oakland. Please note that this is general guidance and does not replace clinical judgement based on the patient's clinical presentation, history, and current clinical status.
These guidelines inform selection and modification of antibiotic therapy based on preliminary blood culture results. They are not intended to replace clinical judgement